Treatment of Urethritis
For urethritis treatment, azithromycin 1g orally in a single dose or doxycycline 100mg orally twice daily for 7 days are the recommended first-line therapies. 1
Diagnosis Before Treatment
Before initiating treatment, confirm urethritis diagnosis by one of the following:
- Mucopurulent or purulent urethral discharge 1
- Gram stain of urethral secretions showing >5 WBC per oil immersion field 1
- Positive leukocyte esterase test on first-void urine or microscopic examination showing >10 WBC per high power field 1
- Perform a validated nucleic acid amplification test (NAAT) on first-void urine or urethral smear to diagnose chlamydial and gonococcal infections 1
First-Line Treatment Options
Recommended Regimens:
- Azithromycin 1g orally in a single dose 1
- Advantages: Single-dose regimen improves compliance and allows for directly observed therapy
- Particularly effective for Mycoplasma genitalium infections 1
OR
- Doxycycline 100mg orally twice daily for 7 days 1
- Highly effective for chlamydial urethritis
Alternative Treatment Options
If first-line treatments cannot be used, consider:
- Erythromycin base 500mg orally four times daily for 7 days 1
- Erythromycin ethylsuccinate 800mg orally four times daily for 7 days 1
- Ofloxacin 300mg orally twice daily for 7 days 1
- Levofloxacin 500mg orally once daily for 7 days 1
Pathogen-Specific Treatment
For Gonococcal Urethritis:
- Ceftriaxone 1g IM or IV as a single dose plus azithromycin 1g orally in a single dose 1
- For cephalosporin allergy: Gentamicin 240mg IM single dose plus azithromycin 2g orally single dose 1
For Trichomonas vaginalis:
- Metronidazole or Tinidazole 2g orally in a single dose 1
Management of Recurrent or Persistent Urethritis
If symptoms persist or recur after initial treatment:
- Confirm objective signs of urethritis are present 1
- Rule out reinfection or non-compliance with initial treatment 1
- If compliant with initial regimen and reexposure excluded, recommended treatment is:
Important Patient Instructions
- Abstain from sexual intercourse until 7 days after therapy is initiated 1
- Return for evaluation if symptoms persist or recur after treatment completion 1
- Symptoms alone, without objective signs or laboratory evidence of urethral inflammation, are not sufficient basis for re-treatment 1
Partner Management
- Refer all sexual partners within the preceding 60 days for evaluation and treatment 1
- Perform urethral swab culture before treatment initiation in patients with positive NAAT for gonorrhea to assess antimicrobial resistance 1
Special Considerations
- HIV infection: Patients with urethritis who are HIV-positive should receive the same treatment regimens as HIV-negative patients 1
- Persistent symptoms beyond 3 months should raise suspicion for chronic prostatitis/chronic pelvic pain syndrome 1
- Testing for other STIs including syphilis and HIV is recommended for patients diagnosed with urethritis 1
Common Pitfalls to Avoid
- Treating without confirming diagnosis - always document objective evidence of urethritis 1
- Failing to test for both gonorrhea and chlamydia 1
- Re-treating based on symptoms alone without objective evidence of persistent infection 1
- Neglecting partner notification and treatment, which can lead to reinfection 1
- Not considering tetracycline-resistant U. urealyticum in cases of recurrent urethritis following doxycycline treatment 1